Allogeneic HSCT With Low-Dose Post-Transplant Cyclophosphamide for GVHD Prevention

Clinical trial NCT06926595 · RECRUITING

Trial details

NCT number: NCT06926595
Sponsor: Milton S. Hershey Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Graft-versus-Host Disease (GVHD)Hematologic Malignancies Allogeneic Stem Cell Transplantation

Start date: 2026-03-09
Primary completion: 2030-11-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.